Philadelphia ends partnership with Philly Fighting COVID for its alleged vaccine misuse

The 22-year-old CEO allegedly took surplus vaccine doses. The group is under investigation.
The 22-year-old CEO allegedly took surplus vaccine doses. The group is under investigation.